Beijing Strong Biotechnologies, Inc. (ASX: 300406) has announced that it recently obtained a Medical Device Registration Certificate issued by the National Medical Products Administration.

The registered product is the Human ABO Blood Group Reverse Typing Erythrocyte Reagent Kit, which is intended for human ABO blood group reverse typing detection. It is for clinical laboratory use only and is not to be used for blood source screening.

The acquisition of this registration certificate enriches the company's product portfolio in the field of in-vitro diagnostics for blood typing.

This development is expected to further enhance the company's core competitiveness and market expansion capabilities, having a positive impact on its future business operations.